NasdaqGS - Delayed Quote USD
Inozyme Pharma, Inc. (INZY)
3.9500
0.0000
(0.00%)
At close: 4:00:00 PM EDT
3.9598
+0.01
+(0.25%)
After hours: 7:35:12 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 29,980 | 3 |
| Sales | 8,819 | 1 |
| Net Shares Purchased (Sold) | 21,161 | 4 |
| Total Insider Shares Held | 791.53k | -- |
| % Net Shares Purchased (Sold) | 2.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| TRECO DOUGLAS A Chief Executive Officer | Sale at price 0.89 per share. | Direct | 7,849 | Apr 2, 2025 |
| TRECO DOUGLAS A Chief Executive Officer | -- | Direct | -- | Apr 1, 2025 |
| SUBRAMANIAN SANJAY Chief Financial Officer | Stock Award(Grant) at price 0.77 per share. | Direct | 1,917 | Mar 31, 2025 |
| WINTON MATTHEW Chief Operating Officer | Stock Award(Grant) at price 0.77 per share. | Direct | 1,917 | Mar 31, 2025 |
| TRECO DOUGLAS A Chief Executive Officer | Stock Award(Grant) at price 4.45 per share. | Direct | 7,610 | Sep 30, 2024 |
| WINTON MATTHEW Chief Operating Officer | Stock Award(Grant) at price 4.45 per share. | Direct | 7,610 | Sep 30, 2024 |
| TRECO DOUGLAS A Chief Executive Officer | Sale at price 6.94 per share. | Direct | 52,210 | Apr 2, 2024 |
| TRECO DOUGLAS A Chief Executive Officer | -- | Direct | -- | Apr 1, 2024 |
| WINTON MATTHEW Chief Operating Officer | Stock Award(Grant) at price 7.66 per share. | Direct | 24,420 | Mar 28, 2024 |
| SUBRAMANIAN SANJAY Chief Financial Officer | Stock Award(Grant) at price 3.57 per share. | Direct | 8,279 | Sep 29, 2023 |
| HOPFNER ROBERT LORNE Director | Purchase at price 4.80 per share. | Indirect | 3,999,998 | Aug 1, 2023 |
| PIVOTAL BIOVENTURE PARTNERS FUND I, L.P. Unknown | Purchase at price 4.80 per share. | Indirect | 3,999,998 | Aug 1, 2023 |
Related Tickers
AFMD Affimed N.V.
0.1815
0.00%
NRXS NeurAxis, Inc.
3.2000
-19.80%
EYEN Eyenovia, Inc.
1.4000
-16.17%
BCLI Brainstorm Cell Therapeutics Inc.
1.1800
-4.84%
KLTO Klotho Neurosciences, Inc.
0.1800
-17.24%
CABA Cabaletta Bio, Inc.
1.7950
-4.52%
ABP Abpro Holdings, Inc.
0.2546
-0.12%
SEPN Septerna, Inc.
9.06
-3.82%
PTIX Protagenic Therapeutics, Inc.
6.14
-10.76%
NCNA NuCana plc
0.0404
-12.93%